These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18425425)
1. The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies. Hamburger AW J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):225-33. PubMed ID: 18425425 [TBL] [Abstract][Full Text] [Related]
2. Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells. Hutcheson IR; Knowlden JM; Hiscox SE; Barrow D; Gee JM; Robertson JF; Ellis IO; Nicholson RI Breast Cancer Res; 2007; 9(4):R50. PubMed ID: 17686159 [TBL] [Abstract][Full Text] [Related]
3. The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells. Lu Y; Zhou H; Chen W; Zhang Y; Hamburger AW Breast Cancer Res Treat; 2011 Feb; 126(1):27-36. PubMed ID: 20379846 [TBL] [Abstract][Full Text] [Related]
4. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873 [TBL] [Abstract][Full Text] [Related]
5. The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells. Awasthi S; Ezelle H; Hassel BA; Hamburger AW Mol Cell Biochem; 2015 Jul; 405(1-2):177-86. PubMed ID: 25876877 [TBL] [Abstract][Full Text] [Related]
6. Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway. Awasthi S; Hamburger AW J Cell Physiol; 2014 Nov; 229(11):1831-41. PubMed ID: 24692179 [TBL] [Abstract][Full Text] [Related]
7. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1. Zhang Y; Akinmade D; Hamburger AW Cancer Lett; 2008 Jul; 265(2):298-306. PubMed ID: 18355957 [TBL] [Abstract][Full Text] [Related]
9. Oligomerization of the Nrdp1 E3 ubiquitin ligase is necessary for efficient autoubiquitination but not ErbB3 ubiquitination. Printsev I; Yen L; Sweeney C; Carraway KL J Biol Chem; 2014 Mar; 289(12):8570-8. PubMed ID: 24519943 [TBL] [Abstract][Full Text] [Related]
10. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells. Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells. Liu B; Ordonez-Ercan D; Fan Z; Edgerton SM; Yang X; Thor AD Int J Cancer; 2007 May; 120(9):1874-82. PubMed ID: 17266042 [TBL] [Abstract][Full Text] [Related]
12. Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer. Ghosh A; Awasthi S; Peterson JR; Hamburger AW Br J Cancer; 2013 Feb; 108(3):557-63. PubMed ID: 23361053 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells. Akinmade D; Talukder AH; Zhang Y; Luo WM; Kumar R; Hamburger AW Br J Cancer; 2008 Mar; 98(6):1132-40. PubMed ID: 18283314 [TBL] [Abstract][Full Text] [Related]
14. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells. Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492 [TBL] [Abstract][Full Text] [Related]
15. Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum. Fry WH; Simion C; Sweeney C; Carraway KL Mol Cell Biol; 2011 Jul; 31(14):3009-18. PubMed ID: 21576364 [TBL] [Abstract][Full Text] [Related]
16. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1. Cao Z; Wu X; Yen L; Sweeney C; Carraway KL Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635 [TBL] [Abstract][Full Text] [Related]
17. The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells. Lyu H; Yang XH; Edgerton SM; Thor AD; Wu X; He Z; Liu B Oncotarget; 2016 Jan; 7(3):2921-35. PubMed ID: 26621843 [TBL] [Abstract][Full Text] [Related]
18. The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3. Hatakeyama J; Wald JH; Rafidi H; Cuevas A; Sweeney C; Carraway KL Sci Signal; 2016 Jun; 9(434):ra65. PubMed ID: 27353365 [TBL] [Abstract][Full Text] [Related]
19. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib. Frolov A; Schuller K; Tzeng CW; Cannon EE; Ku BC; Howard JH; Vickers SM; Heslin MJ; Buchsbaum DJ; Arnoletti JP Cancer Biol Ther; 2007 Apr; 6(4):548-54. PubMed ID: 17457047 [TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors. Ingalla EQ; Miller JK; Wald JH; Workman HC; Kaur RP; Yen L; Fry WH; Borowsky AD; Young LJ; Sweeney C; Carraway KL J Biol Chem; 2010 Sep; 285(37):28691-7. PubMed ID: 20628057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]